Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank13
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-254.05%
↓ 36% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-187.07%
Historical baseline
PeriodValueYoY Change
TTM-254.05%+66.7%
2022-761.91%-
20210.00%-
20200.00%+100.0%
2019-683.56%-699.3%
2018-85.52%-60.0%
2017-53.46%-125.0%
2016-23.76%-954.7%
2015-2.25%+63.9%
2014-6.23%-